DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tegretol-XR (Carbamazepine) - Adverse Event Reports - Serious Event

 



Index of reports > Cases resulting in a serious event (8)

     Convulsion (3)Surgery (3)Myalgia (2)Brain Neoplasm Malignant (2)Fatigue (2)Nausea (1)Blood Potassium Decreased (1)Haemorrhagic Diathesis (1)Platelet Count Decreased (1)Neuralgia (1)

Below is the selection of adverse event reports related to Tegretol-XR (Carbamazepine) that includes cases resulting in a serious event.

Adverse event in female receiving Tegretol-XR (Carbamazepine)

Reported by a individual with unspecified qualification from United States on 2007-10-12

Patient: female

Adverse reactions / side effects: Contusion, Haemorrhage, Bone Pain, Platelet Count Increased, Convulsion, Myalgia, Platelet Morphology Abnormal, RED Blood Cell Count Decreased, Haemorrhagic Diathesis, Platelet Count Decreased, Peripheral Nerve Destruction, Neuralgia

Suspect drug(s):
Tegretol-XR (Carbamazepine)



Adverse event in male receiving Tegretol-XR (Carbamazepine)

Reported by a consumer/non-health professional from United States on 2007-07-27

Patient: male

Adverse reactions / side effects: Nausea, TIC, Aggression, Convulsion

Suspect drug(s):
Keppra

Tegretol-XR
    Dosage: 100 mg, bid



Adverse event in 24 year old male receiving Tegretol-XR (Carbamazepine)

Reported by a consumer/non-health professional from United States on 2007-07-24

Patient: 24 year old male

Adverse reactions / side effects: Drug Level Below Therapeutic, Blood Potassium Decreased, Unresponsive TO Stimuli, Anticonvulsant Drug Level Decreased, Drug Interaction, Convulsive Threshold Lowered, Status Epilepticus, Convulsion

Adverse event resulted in: hospitalization

Suspect drug(s):
Herbal Extracts NOS

Tegretol-XR
    Dosage: 400 mg, bid
    Administration route: Oral



Adverse event in male receiving Tegretol-XR (Carbamazepine)

Reported by a physician from United States on 2007-07-10

Patient: male, weighing 82.6 kg (181.6 pounds)

Adverse reactions / side effects: Myalgia, Malaise, Fatigue, Neck Pain, Chills, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Pyrexia, RED Blood Cell Sedimentation Rate Increased

Adverse event resulted in: life threatening event

Suspect drug(s):
Tegretol-XR (Carbamazepine)



Adverse event in 56 year old female receiving Tegretol-XR (Carbamazepine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-23

Patient: 56 year old female, weighing 102.0 kg (224.4 pounds)

Adverse reactions / side effects: Fatigue, Anaemia, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Tegretol-XR (Carbamazepine)

Other drugs received by patient: Lisinopril; Zocor; Celexa; Lyrica; Topamax



Adverse event in 25 year old female receiving Tegretol-XR (Carbamazepine)

Reported by a physician from United Kingdom on 2007-04-25

Patient: 25 year old female

Adverse reactions / side effects: Brain Neoplasm Malignant, Surgery

Suspect drug(s):
Tegretol-XR (Carbamazepine)



Adverse event in 25 year old female receiving Tegretol-XR (Carbamazepine)

Reported by a physician from United Kingdom on 2007-03-07

Patient: 25 year old female

Adverse reactions / side effects: Brain Neoplasm Malignant, Surgery

Suspect drug(s):
Tegretol-XR (Carbamazepine)



Adverse event in 68 year old female receiving Tegretol-XR (Carbamazepine)

Reported by a physician from United States on 2007-02-09

Patient: 68 year old female, weighing 81.6 kg (179.6 pounds)

Adverse reactions / side effects: Weight Increased, Surgery

Suspect drug(s):
Tegretol-XR
    Dosage: 1200 mg, qd
    Indication: Trigeminal Neuralgia
    Start date: 2004-03-01
    End date: 2006-01-01

Tegretol-XR
    Dosage: 200 mg, qd
    Start date: 2006-01-01

Other drugs received by patient: Mirapex; Xanax; Iron Preparations

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009